Out-of Pocket Payments in Patients With Lymphedema
Overview
Primary lymphedema is a chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. The investigators aim was to analyze the distributive effects of OOPP for primary lymphedema patients in France. A prospective, multicenter study will be conducted in France in 2015 on patients with primary lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. The investigators will combine concentration curves and concentration indices to assess the distributive effects.
Full Title of Study: “Out-of Pocket Payments in Patients With Primary Lymphedema in France and Inequities of Access to Healthcare”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: October 2017
Interventions
- Other: Out of pocket payments in patients
Clinical Trial Outcome Measures
Primary Measures
- The mean monthly out-of-pocket payment as assessed by an online self-questionnaire
- Time Frame: 6 months
Participating in This Clinical Trial
Inclusion Criteria
- Patient aged over six years, with primary lymphedema, regardless of the severity of the disease; – Patient treated in one of the centres participating in the study; – Patient (and her legal representative for minors) who gave her written consent [or did not refuse to participate, according to local Law]; – Patient with Internet access and an active email address. Exclusion criteria:
- Patients with concomitant chronic venous insufficiency; – Patient not covered by any health care insurance scheme; – People protected under the law.
Gender Eligibility: All
Minimum Age: 6 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University Hospital, Montpellier
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Gregoire MERCIER, MD, PHD, Principal Investigator, University Hospital, Montpellier
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.